Related Experiment Video
Updated: Jun 3, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Systems biology of tuberculosis
Nagasuma Chandra1, Dhiraj Kumar, Kanury Rao
1Bioinformatics Centre, Indian Institute of Science, Bangalore 560012, India. nchandra@serc.iisc.ernet.in
Indian researchers are using systems biology to study Mycobacterium tuberculosis (TB) and its host interactions. These studies provide insights into essential proteins, pathways, and drug targets for combating TB.
Area of Science:
- Systems biology
- Mycobacterium tuberculosis research
- Host-pathogen interactions
Background:
- Systems biology integrates diverse data to understand biological systems and their responses.
- Genome-scale data for Mycobacterium tuberculosis facilitates systems-level investigations.
- Indian research efforts focus on Mycobacterium tuberculosis and host interactions.
Purpose of the Study:
- To review Indian systems-level studies on Mycobacterium tuberculosis and host interactions.
- To highlight insights gained into pathogen survival, host factors, and pathogenesis.
- To discuss drug target identification strategies and drug resistance.
Main Methods:
- Modeling and simulation of metabolic pathways and protein-protein interaction networks.
- Experimental studies of host-pathogen interactions using siRNA techniques.
- Development of a drug target identification pipeline integrating interactome, reactome, genome, pocketome, and transcriptome data.
Main Results:
- Identification of essential proteins for bacterial survival and influential network proteins.
- Characterization of highly connected pathways and host factors in TB infection.
- Gained insights into autophagy, pathogenesis, and the emergence of drug resistance.
Conclusions:
- Systems biology approaches provide a global perspective on Mycobacterium tuberculosis and host interactions.
- Integrated analyses are crucial for identifying novel drug targets and understanding drug resistance.
- Exploring host factors presents a promising avenue for TB therapeutic strategies.
Related Concept Videos
Tuberculosis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

